Table 4.
Adjusted Odds of High Trust in Diagnosing Doctor According to Personal, Health Care, and Cancer-Related Factors (N = 704)
Patient characteristics | Model 1 | Model 2† |
---|---|---|
OR (95% CI) | OR (95% CI) | |
Trust regular provider | ||
(Ref: not highest trust) | ||
Highest trust | 3.44 (2.27–5.21)*** | 3.59 (2.30–5.60)*** |
Race (ref: white) | ||
Black | 0.65 (0.36–1.18) | |
Hispanic (English) | 0.29 (0.11–0.80)* | |
Hispanic (Spanish) | 0.43 (0.17–1.06) | |
Insurance (ref: no insurance) | ||
Public | 0.68 (0.28–1.66) | |
Private | 0.81 (0.34–1.89) | |
Number of recent exams (ref: 0 exams) | ||
1 | 0.48 (0.81–1.26) | |
2 | 0.94 (0.38–2.31) | |
3 | 0.85 (0.36–2.01) | |
Number of comorbidities (ref: (0 comorbidities) | ||
1 | 0.95 (0.55–1.63) | |
2+ | 1.16 (0.59–2.28) | |
Time with regular doctor (ref: <1 year) | ||
1–5 years | 0.90 (0.34–2.35) | |
6–10 years | 0.94 (0.35–2.47) | |
>10 years | 0.94 (0.35–2.53) | |
Cancer stage (ref: stage 0) | ||
1 | 0.82 (0.43–1.54) | |
2 | 0.82 (0.40–1.66) | |
3 | 0.82 (0.34–1.97) | |
4 | 2.11 (0.23–18.95) | |
Days since diagnosis (ref: <85) | ||
85–108 | 0.56 (0.29–1.09) | |
109–148 | 0.64 (0.33–1.25) | |
>149 | 0.53 (0.27–1.02) | |
Chemotherapy (ref: no chemo) | ||
Yes | 1.09 (0.62–1.91) | |
Mastectomy (ref: no mastectomy) | ||
Yes | 1.18 (0.73–1.89) |
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
†The following variables are included in the model: age, marital status, income, education